Laboratory of Toxicology, Department of Toxicology & Pharmacology, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Toxicol Mech Methods. 2006;16(7):365-72. doi: 10.1080/15376520600620125.
The essential oil from Satureja Khuzestanica Jamzad (SKEO), an endemic plant from Iran, was evaluated for its activity against inflammatory bowel disease (IBD). SKEO was examined on the experimental mouse model of inflammatory bowel disease, which is acetic acid-induced colitis. Prednisolone was used as the standard drug for comparison. Biochemical, macroscopic, and microscopic examinations of colon were performed. Lipid peroxidation significantly increased in acetic acid-treated mice in comparison to the normal group (4.88 vs. 3.02 mumol/g) and was significantly restored by SKEO (500, 1000, 1500 ppm) and prednisolone treatment. The mean percentage of decreases of lipid peroxidation in SKEO (500, 1000, 1500 ppm)- and prednisolone-treated groups were 10.5, 28.5, 42.85, and 33.33 of control, respectively. The myeloperoxidase activity significantly increased in acetic acid-treated mice in comparison to the normal group (4.1 vs. 0.8 U/g) and significantly restored in SKEO (1000 and 1500 ppm)- and prednisolone-treated groups. The mean percentage of decreases of myeloperoxidase activity in SKEO (1000 and 1500 ppm)- and prednisolone-treated groups were 24.56, 50, and 52.63 of control, respectively. SKEO (1000 and 1500 ppm)- and prednisolone-treated groups showed significantly lower score values of macroscopic and microscopic characters when compared to the acetic acid-treated group. The beneficial effect of SKEO (1500 ppm) was comparable to that of prednisolone. Known antioxidant, antimicrobial, antiinflammatory, and antispasmodic potentials of Satureja Khuzestanica may be the mechanisms by which this plant protects animals against experimentally induced IBD. Proper clinical investigation should be carried out to confirm the activity in human disease.
来自伊朗特有植物 Satureja Khuzestanica Jamzad(SKEO)的精油,其抗炎性肠病(IBD)活性已被评估。SKEO 在实验性肠炎模型中进行了研究,该模型为乙酸诱导的结肠炎。将泼尼松龙用作比较的标准药物。对结肠进行生化、宏观和微观检查。与正常组(4.88 对 3.02 µm ol/g)相比,乙酸处理的小鼠中脂质过氧化显著增加,并且 SKEO(500、1000、1500 ppm)和泼尼松龙处理明显恢复。SKEO(500、1000、1500 ppm)-和泼尼松龙处理组的脂质过氧化降低率分别为对照的 10.5%、28.5%、42.85%和 33.33%。与正常组相比,乙酸处理的小鼠中髓过氧化物酶活性(4.1 对 0.8 U/g)显著增加,并且在 SKEO(1000 和 1500 ppm)-和泼尼松龙处理组中显著恢复。SKEO(1000 和 1500 ppm)-和泼尼松龙处理组的髓过氧化物酶活性降低率分别为对照的 24.56%、50%和 52.63%。与乙酸处理组相比,SKEO(1000 和 1500 ppm)-和泼尼松龙处理组的宏观和微观特征评分值明显较低。SKEO(1500 ppm)的有益作用可与泼尼松龙相媲美。Satureja Khuzestanica 的已知抗氧化、抗菌、抗炎和抗痉挛潜力可能是该植物保护动物免受实验性 IBD 侵害的机制。应进行适当的临床研究以确认其在人类疾病中的活性。